Methotrexate Monitoring in Dermatology— A Retrospective Cohort Study

Zufall, Alina; Rama, Bharath; Ninmer, Emily K.; Vittitow, Stephany L.; Saito, Miyabi; Noland, Mary; Flowers, Richard

doi:10.36849/jdd.5790

Search citation statements

Order By: Relevance

Paper Sections

Select...

Methotrexate-pharmacological Aspects1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This precursor was initially used empirically in 1951 for the treatment of psoriasis and rheumatoid arthritis. The first scientific data regarding the therapeutic benefits of MTX in psoriasis were published in 1958, and, since 1972, it has been approved by the FDA for the therapy of this condition [7].…”

Section: Methotrexate-pharmacological Aspectsmentioning

confidence: 99%

An Overview of Methotrexate Indications in Skin Diseases

Mocanu,

Procopciuc,

Gheucă-Solovăstru

et al. 2024

Medicina

View full text Add to dashboard Cite

Methotrexate is an immunosuppressive drug with remarkable therapeutic results in the treatment of autoimmune and proliferative skin diseases. Although it has been more than half a century since it was first introduced into the therapeutic arsenal of dermatologists, there are currently no standardized therapeutic protocols regarding the prescription of methotrexate in dermatology, with the exception of psoriasis treatment. This review aims to highlight the indications and benefits of methotrexate beyond psoriasis, with a focus on a wide range of inflammatory, vesiculobullous, and proliferative dermatological pathologies.

show abstract

Section: Methotrexate-pharmacological Aspectsmentioning

confidence: 99%